Citations

Clear

3942 citation(s) found for "To, Van".

Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory Death
Zhou, Joyce , Sise, Meghan E. , Drezek, Kamila , Wolfe, Stanley B. , Osho, Asishana A. , Prario, Monica N. , Rabi, S. Alireza , Michel, E., Tsao, Lana, Coglianese, Erin , Doucette, Meaghan, Newton‐Cheh, Christopher , Thomas, Sunu, Sutaria, Nilay, Schoenike, Mark, Christ, Anastasia M. , Villavicencio, Mauricio A. , Madsen, Joren C. , Pierson, Richard N. , D’Alessandro, David A. , Zhou, Joyce C , Ton, Van-Khue , Christ, Anastasia M , Paneitz, Dane C , Villavicencio, Mauricio, Madsen, Joren C , Pierson, Richard , Lewis, Gregory D , D'Alessandro, David A , Zlotoff, Daniel A , Wolfe, Stanley , Osho, Asishana , Michel, Eriberto , Ton, Van‐Khue , Lewis, Gregory D.

Mayo Clinic

Journal of the American Heart Association | October 8, 2024 | Volume: 13 | Issue: 20 | Pages: No page available

10.1161/jaha.124.035443 | PMID 39377217 Get It

Background Transplantation using hearts obtained through donation after circulatory death (DCD) is increasing, but data on recipient renal outcomes are limited. Methods and Results Patients at a single institution who underwent heart transplantation using organs procured through DCD or donation after brain death (DBD) from April 2016 to August 2022 were included in this retrospective cohort study. Hemodynamic measures were collected via right heart catheterization performed 1 week after transplantation. Posttransplantation renal outcomes included estimated glomerular filtration rate at 1 week, 4 weeks, and 16 weeks, and the incidence of acute kidney injury (AKI) and renal replacement therapy within 1 week. The analysis included 225 patients (55 recipients of DCD). Baseline characteristics were comparable between recipients of DCD and DBD. Renal outcomes within 1 week posttransplantation in recipients of DCD were similar to recipients of DBD, including percent change in estimated glomerular filtration rate (−37.9% [−58.6 to −6.2] versus −31.9% [−52.4 to −9.9]; P =0.91), incidence of AKI (47.3% versus 46.5%; P >0.99) and incidence of renal replacement therapy (3.6% versus 4.7%; P >0.99). Recipients of DCD with AKI within 1 week (“early AKI”) did not recover to baseline estimated glomerular filtration rate (75.8 [60.2–91.3] mL/min per 1.73 m 2 ) by week 16 (59.3 [46.9–73.6] mL/min per 1.73 m 2 ; P =0.002), whereas recipients without early AKI exhibited comparable estimated glomerular filtration rate to baseline by week 4 (84.5 [70.8–98.5] mL/min per 1.73 m 2 ; P =0.084). Similar trends were observed in recipients of DBD. Conclusions Recipients of DCD demonstrated similar renal outcomes compared with recipients of DBD, supporting the ongoing use of DCD transplantation. Early AKI was associated with persistent renal dysfunction for recipients of both DCD and DBD.
Prenatal Ultrasonographic Features Associated With ARSL and X‐Linked Chondrodysplasia Punctata 1 (CDPX1): Literature Review and Case Series
Broeren, Eleanor , Stover, Samantha, Bennett, Katya, Giordano, Jessica L. , Galloway, Stephanie, Lauzon, Julie, Rust, Laura, Suerink, Manon , Haeringen, Arie van , Team, Australian Genomic Autopsy Study, Reimers, Rebecca, Giordano, Jessica , Broeren, Eleanor C , Stover, Samantha R. , Team, Australian Genomic Autopsy Study, Reimers, Rebecca

Mayo Clinic

Prenatal Diagnosis | October 8, 2024 | Volume: 44 | Issue: 13 | Pages: 1663-1670

10.1002/pd.6649 | PMID 39313411 Get It

ABSTRACT Background Chondrodysplasia punctata 1 (CDPX1) is an X‐linked recessive disorder of cartilage and bone development characterized by stippling on the cartilage and bone, flattened nasal bridge, and brachydactyly, or short fingers. CDPX1 has been associated with variants in the ARSL gene and is known to manifest prenatally, however, there has been no systematic literature review on this evidence. Aims Here, we reviewed the current literature on prenatal manifestations of CDPX1, and additionally introduce previously unpublished cases. Materials & Methods A systematic review of the literature was performed. Additionally, a GeneMatcher submission was created and a call for cases was presented at the Fetal Sequencing Consortium meetings to find previously unpublished cases. Results For the 22 fetuses reported here, we found that 55% had nasal hypoplasia, 41% had bony stippling or calcifications, 32% had polyhydramnios, 5% had oligohydramnios, 23% had shortened long bones, 23% had spinal canal stenosis, 18% had ventriculomegaly, 9% had brachydactyly/brachytelephalangy, 9% had clubbed feet, 9% had premature rupture of membranes, and 9% had intraventricular hemorrhage detected through sonography or radiography. We also found 17 unique variants in ARSL for these 22 fetuses. Discussion A previously unpublished association of ARSL variants with intrauterine fetal death or stillbirth has been noted in this study. It is also possible that intracranial hemorrhage is an underrecognized feature associated with CDPX1 variation. However, there have been challenges in applying ACMG criteria to ARSL, a gene without an associated Variant Curation Expert Panel. Conclusion This literature review and case series highlights which features of CDPX1 manifest prenatally, as well as introduces new phenotypes that have not been previously identified.
Microsurgical Treatment of Intracranial Dural Arteriovenous Fistulas: A Collaborative Investigation From the Multicenter Consortium for Dural Arteriovenous Fistula Outcomes Research
Raygor, Kunal P. , Abdelsalam, Ahmed , Raper, Daniel , Guniganti, Ridhima , Durnford, Andrew , Brinjikji, Waleed , Abecassis, Isaac Josh, Polifka, Adam , Samaniego, Edgar A. , Kwasnicki, Amanda , Potgieser, Adriaan R. E., Tada, Yoshiteru , Kansagra, Akash P. , Satomi, Junichiro, Eatz, Tiffany , Peterson, Eric C. , Starke, Robert M., Dijk, J. Marc C. van , Hayakawa, M. , Gross, Bradley A. , Fox, W. Christopher, Kim, Louis J. , Sheehan, Jason , Bulters, Diederik , Zipfel, Gregory J. , Abla, Adib A. , Alaraj, Ali , Eatz, Tiffany , Alaraj, Ali , Samaniego, Edgar A , van DijK, J Marc C , Abla, Adib , Bulters, Diederik O , Tonetti, Daniel A. , Giordan, Enrico , Chen, Ching‐Jen , Levitt, Michael R. , Derdeyn, Colin P. , Chen, Stephanie , Peterson, Eric C., Amin-Hanjani, Sepideh , Gross, Bradley , Fox, W Christopher , Kim, Louis J. , Lanzino, Giuseppe , Du, Rose , Lai, Pui Man Rosalind

Mayo Clinic

Neurosurgery | October 8, 2024 | Volume: 96 | Issue: 5 | Pages: 1023-1034

10.1227/neu.0000000000003204 | PMID 39471093 Get It

BACKGROUND AND OBJECTIVES: First-line therapy for most intracranial dural arteriovenous fistulas (dAVFs) is endovascular embolization, but some require microsurgical ligation due to limited endovascular accessibility, anticipated lower cure rates, or unacceptable risk profiles. We investigated the most common surgically treated dAVF locations and the approaches and outcomes of each. METHODS: The Consortium for Dural Arteriovenous Fistula Outcomes Research database was retrospectively reviewed. Patients who underwent dAVF microsurgical ligation were included. Patient demographics, angiographic information, surgical details, and postoperative outcomes were collected. The 5 most common surgically treated dAVF locations were analyzed about used surgical approaches and postoperative outcomes. Univariate analyses were performed with statistical significance set at a threshold of P < .05. RESULTS: In total, 248 patients in the Consortium for Dural Arteriovenous Fistula Outcomes Research database met inclusion criteria. The 5 most common surgically treated dAVF locations were tentorial, anterior cranial fossa (ACF), transverse-sigmoid sinus (TSS), convexity/superior sagittal sinus (SSS), and torcular. Most tentorial dAVFs were approached using a suboccipital, lateral supracerebellar infratentorial approach (39.3%); extended retrosigmoid approach (ERS) (25%); or posterior subtemporal approach (19.6%). All ACF dAVFs used a subfrontal approach; 5.3% also included an anterior interhemispheric approach. Most TSS dAVFs were ligated via ERS (31.3%) or subtemporal (31.3%) approaches. All convexity/SSS dAVFs used an interhemispheric approach. All torcular dAVFs used the suboccipital, lateral supracerebellar infratentorial approach, with 10.5% undergoing simultaneous ERS craniotomy. Angiographic occlusion rates after microsurgery were 85.5%, 100%, 75.8%, 79.2%, and 73.7% for tentorial, ACF, TSS, convexity/SSS, and torcular dAVFs, respectively ( P = .02); the permanent neurological complication rates were 1.8%, 2.6%, 9.1%, 0%, and 0% ( P = .31). There were no statistically significant differences in development of complications ( P = .08) or Modified Rankin Scale at the last follow-up ( P = .11) by fistula location. CONCLUSION: Although endovascular embolization is the first-line treatment for most intracranial dAVFs, surgical ligation is an important alternative. ACF and tentorial fistulas particularly demonstrate high rates of postoperative obliteration.
Defining standards for fluoroscopy in gastrointestinal endoscopy using Delphi methodology
Khalaf, Kareem , Pawlak, Katarzyna M. , Alkandari, Asma , Baron, Todd H. , Bechara, Robert , Binda, Cecilia , Chen, Yen‐I , Moura, Eduardo Guimarães Hourneaux de , Forbes, Nauzer , James, Paul, Martin, Harry , May, Gary R. , Mosko, Jeffrey D. , Oyeleke, Ganiyat K. , Petersen, Bret T. , Saxena, Payal , Sethi, Amrita , Sharaiha, Reem Z. , Tang, Raymond S. , Villarroel, Mariano , Hooft, Jeanin E. van , Renteln, Daniel von , Walsh, Catharine M. , Aberin, Tricia, Banavage, Dawn, Chen, Jowell Akina, Clancy, James, Drake, Heather, Im, Melanie, Low, Chooi Peng, Myszko, Alexandra, Navarro, Krista, Redman, Jessica, Reyes, Wayne, Weinstein, Faina, Na, Caleb, Tham, Daniel , He, Tony , Malipatil, Sharan B., Gimpaya, Nikko , Kundra, Arjun , Grover, Samir C. , Barkun, Alan N , Bechara, Robert , Binda, Cecilia , de Moura, Eduardo , Hassan, Cesare , Kahaleh, Michel , Sharaiha, Reem Z , Villarroel, Mariano , van Hooft, Jeanin E , Voermans, Rogier P , von Renteln, Daniel , Walsh, Catharine M , Gupta, Sunil , Fujiyoshi, Yusuke , Grover, Samir C , Causada Calo, Natalia S , Pawlak, Katarzyna M , Adler, Douglas G. , Barkun, Alan , Berzin, Tyler M. , Cai, Ming‐Yan , Carrara, Silvia , Fugazza, Alessandro , Hassan, Cesare , James, Paul D., Kahaleh, Michel , Maselli, Roberta , Repici, Alessandro , Spadaccini, Marco , Teshima, Christopher , Voermans, Rogier P. , Clancy, James, Reyes, Wayne, Gupta, Sunil , Mokhtar, Ahmed H., Gholami, Reza

Mayo Clinic

Endoscopy International Open | October 7, 2024 | Volume: 12 | Issue: 11 | Pages: E1315-E1325

10.1055/a-2427-3893 | PMID 39559412 Get It

Abstract Background and study aims Use of fluoroscopy in gastrointestinal endoscopy is an essential aid in advanced endoscopic interventions. However, it also raises concerns about radiation exposure. This study aimed to develop consensus-based statements for safe and effective use of fluoroscopy in gastrointestinal endoscopy, prioritizing the safety and well-being of healthcare workers and patients. Methods A modified Delphi approach was employed to achieve consensus over three rounds of surveys. Proposed statements were generated in Round 1. In the second round, panelists rated potential statements on a 5-point scale, with consensus defined as ≥80% agreement. Statements were subsequently prioritized in Round 3, using a 1 (lowest priority) to 10 (highest priority) scale. Results Forty-six experts participated, consisting of 34 therapeutic endoscopists and 12 endoscopy nurses from six continents, with an overall 45.6% female representation (n = 21). Forty-three item statements were generated in the first round. Of these, 31 statements achieved consensus after the second round. These statements were categorized into General Considerations (n = 6), Education (n = 10), Pregnancy (n = 4), Family Planning (n = 2), Patient Safety (n = 4), and Staff Safety (n = 5). In the third round, accepted statements received mean priority scores ranging from 7.28 to 9.36, with 87.2% of statements rated as very high priority (mean score ≥ 9). Conclusions This study presents consensus-based statements for safe and effective use of fluoroscopy in gastrointestinal endoscopy, addressing the well-being of healthcare workers and patients. These consensus-based statements aim to mitigate risks associated with radiation exposure while maintaining benefits of fluoroscopy, ultimately promoting a culture of safety in healthcare settings.
7829 Hydrocortisone Vs Prednisone During Recovery Following Surgical Cure For Endogenous Hypercortisolism: A Longitudinal Observational Study
Sandooja, Rashi , Garcia, Raul Gregg , Zhang, Catherine, Achenbach, Sara J., Atkinson, Elizabeth J. , Garcia, Raul G , Saini, Jasmine , Gompel, Jamie J. Van , Young, William F. , Bancos, Irina

Mayo Clinic

Journal of the Endocrine Society | October 5, 2024 | Volume: 8 | Issue: Supplement_1 | Pages: No page available

10.1210/jendso/bvae163.206 Get It

Abstract Disclosure: R. Sandooja: None. J. Saini: None. R. Gregg garcia: None. C. Zhang: None. S. Achenbach: None. E. Atkinson: None. J. Van Gompel: None. W.F. Young: None. I. Bancos: None. Hydrocortisone vs Prednisone During Recovery Following Surgical Cure for Endogenous Hypercortisolism: A Longitudinal Observational Study Introduction: Glucocorticoid withdrawal syndrome (GWS) is a constellation of symptoms that occurs after successful surgery for endogenous hypercortisolism. The objective of this study is to compare hydrocortisone versus prednisone on GWS symptoms. Methods: Study design: Single-center prospective longitudinal cohort study, 2019-2023. Participants: Adults with Cushing syndrome (CS) and mild autonomous cortisol secretion (MACS) with post-operative adrenal insufficiency treated with either hydrocortisone or prednisone for glucocorticoid replacement. Measurements: Clinical and biochemical severity scores for hypercortisolism were calculated. Quality of life (QOL) was assessed using Short Form-36 (SF-36) and Cushing QOL surveys. GWS was assessed using weekly AddiQoL surveys for the first 12 weeks after surgery. Results: Of 131 patients, 91 (69%) patients were treated with hydrocortisone and 40 (31%) with prednisone. No differences in age (median age 51 vs 53 years, P=0.62), sex (84 vs 85% women, P=0.83), etiology of hypercortisolism (ACTH-dependent: 44% vs 48%, P=0.26), clinical severity of hypercortisolism (median score 13 vs 12, P=0.97), or biochemical severity of hypercortisolism (median score of 6 in both, P=0.31) were noted between groups. When assessed at 4-, 8-, and 12-weeks post-surgery, the prevalence and trajectory of symptoms (fatigue, myalgias/arthralgias, sleep, headaches, nausea, weakness) were similar in patients treated with hydrocortisone and prednisone (P&gt;0.05 for all). However, patients treated with prednisone were less likely to report mood changes (8.5% vs 20.9%, P= 0.004) compared to those treated with hydrocortisone. When compared to the presurgical baseline, the overall Cushing QOL score 12 weeks post-surgery improved in both groups (mean delta 8.9 vs 13.0, P=0.21). No differences in the hydrocortisone vs prednisone treatment were found in the SF-36 physical component score (mean delta of -1.7 vs 0.3, P=0.23) and SF-36 mental component score (mean delta 2.3 vs 5.0, P=0.22). Using multivariable analysis, age (estimate 0.22, P= 0.005), clinical severity score (estimate -0.73, P&lt;0.001), female sex (estimate -5.45, P= 0.046) but not glucocorticoid type (estimate -0.06, P=0.98) were associated with the overall GWS symptom burden at 12 weeks. Conclusion: Use of prednisone after curative surgery for hypercortisolism was associated with lower mood symptoms, but did not impact the overall severity or trajectory of other symptoms associated with GWS. Baseline clinical severity of hypercortisolism, age, and female sex were associated with GWS burden. Presentation: 6/1/2024
You are safe here: A flyer with re‐orientating messages for families of patients with delirium in the intensive care unit
Nydahl, Peter , Chahdi, Mohamed , Debue, Anne‐Sophie , Deffner, Teresa , Galazzi, Alessandro , Gallie, Louise , La‐Calle, Gabriel Heras, Krotsetis, Susanne, Lewko, Agnieszka , Liu, Keibun , Paulino, Maria Carolina , Prigge, Arvid, Haken, Rebecca von , Calle, Gabriel Heras La , Nydahl, Peter , Lindroth, Heidi , Boogaard, Mark van den , Debue, Anne-Sophie

Mayo Clinic

Nursing in Critical Care | October 4, 2024 | Volume: 29 | Issue: 6 | Pages: 1276-1279

10.1111/nicc.13169 | PMID 39362828 Get It

AbstractPatients in delirium require trustful communication and re‐orientation. We developed a flyer with positive, re‐orientating suggestions for families of delirious patients in intensive care units. Suggestions include creating a safe environment, interpreting unusual behaviours positively and fostering mental resilience. Additionally, families are encouraged to prioritize their own well‐being, recognizing their crucial role in supporting their loved ones. This flyer offers practical strategies across four key areas: ensuring security and orientation, reframing noises and body experiences, managing agitation and reshaping perceptions. By equipping families with knowledge and tools, this resource aims to promote understanding, resilience and strength to humanize delirium care.
Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis
Hazelwood, Emma , Manzano, Catalina Lopez , Vincent, Emma E. , Albanes, Demetrius , Bishop, D. Timothy , Marchand, Loı̈c Le , Peters, Ulrike , Murphy, Gwen , Samadder, N. Jewel , Guelpen, Bethany Van , Papadimitriou, Nikos , Lopez Manzano, Catalina , Bishop, D Timothy , Marchand, Loïc Le , Ulrich, Cornelia M , Peters, Ulrike , Murphy, Gwen , Samadder, N Jewel , Anderson, Laura , Gunter, Marc J , Murphy, Neil , Van Guelpen, Bethany , Papadimitriou, Nikos , Vincent, Emma E , Albanes, Demetrius , Hazelwood, Emma , Ulrich, Cornelia M. , Anderson, Laura N. , Gunter, Marc J. , Murphy, Neil

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 3, 2024 | Volume: 33 | Issue: 12 | Pages: 1727-1732

10.1158/1055-9965.epi-24-0926 | PMID 39361354 Get It

Abstract Background: Epidemiological and laboratory-based studies have provided conflicting evidence for a role of ghrelin in colorectal cancer development. We conducted two-sample Mendelian randomization (MR) analyses to evaluate evidence for an association of circulating ghrelin and colorectal cancer risk overall and by sex, cancer subsite, and age at diagnosis. Methods: Genetic instruments proxying plasma total ghrelin levels were obtained from a recent genome-wide association study of 54,219 participants. Summary data for colorectal cancer risk were obtained from a recent meta-analysis of several genetic consortia (up to 73,673 cases and 86,854 controls). A two-sample MR approach and several sensitivity analyses were applied. Results: We found no evidence for an association of genetically predicted plasma total ghrelin levels and colorectal cancer risk (0.95, 95% confidence interval, 0.81–1.12; R2 of ghrelin genetic instruments: 4.6%), with similarly null results observed when stratified by sex, anatomical subsite, and for early-onset colorectal cancer. Conclusions: Our study suggests that plasma ghrelin levels are unlikely to have a causal relationship with overall, early-onset, and sex- and cancer subsite–stratified colorectal cancer risk. Impact: This large-scale analysis adds to the growing body of evidence that plasma total ghrelin levels are not associated with colorectal cancer risk.
Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players
Miner, Annalise E. , Groh, Jenna R. , Balcer, Laura J. , Bernick, Charles , Zetterberg, Henrik, Blennow, Kaj, Peskind, Elaine R. , Martin, Brett , Palmisano, Joseph , Banks, Sarah J. , Wethe, Jennifer V. , Amerongen, Suzan van , Shenton, Martha E. , Reiman, Eric M. , Alosco, Michael L. , Wethe, Jennifer V , Shenton, Martha E , Tripodis, Yorghos , Adler, Charles H. , Zetterberg, Henrik , Blennow, Kaj , Ashton, Nicholas J. , Gaudet, Charles E. , Barr, William , Cantu, Robert C. , Dodick, David W. , Katz, Douglas I. , Mez, Jesse , Cummings, Jeffrey L. , Stern, Robert A.

Mayo Clinic

Alzheimer's & Dementia | October 1, 2024 | Volume: 20 | Issue: 11 | Pages: 7529-7546

10.1002/alz.14231 | PMID 39351900 Get It

AbstractINTRODUCTIONBlood‐based biomarkers offer a promising approach for the detection of neuropathologies from repetitive head impacts (RHI). We evaluated plasma biomarkers of amyloid, tau, neurodegeneration, and inflammation in former football players.METHODSThe sample included 180 former football players and 60 asymptomatic, unexposed male participants (aged 45–74). Plasma assays were conducted for beta‐amyloid (Aβ) 40, Aβ42, hyper‐phosphorylated tau (p‐tau) 181+231, total tau (t‐tau), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), interleukin‐6 (IL‐6), Aβ42/p‐tau181 and Aβ42/Aβ40 ratios. We evaluated their ability to differentiate the groups and associations with RHI proxies and traumatic encephalopathy syndrome (TES).RESULTSP‐tau181 and p‐tau231(padj = 0.016) were higher and Aβ42/p‐tau181 was lower(padj = 0.004) in football players compared to controls. Discrimination accuracy for p‐tau was modest (area under the curve [AUC] = 0.742). Effects were not attributable to AD‐related pathology. Younger age of first exposure (AFE) correlated with higher NfL (padj = 0.03) and GFAP (padj = 0.033). Plasma GFAP was higher in TES‐chronic traumatic encephalopathy (TES‐CTE) Possible/Probable (padj = 0.008).DISCUSSIONPlasma p‐tau181 and p‐tau231, GFAP, and NfL may offer some usefulness for the characterization of RHI‐related neuropathologies.Highlights Former football players had higher plasma p‐tau181 and p‐tau231 and lower Aβ42/ptau‐181 compared to asymptomatic, unexposed men. Younger age of first exposure was associated with increased plasma NfL and GFAP in older but not younger participants. Plasma GFAP was higher in participants with TES‐CTE possible/probable compared to TES‐CTE no/suggestive.
The Use of Artificial Intelligence for Orthopedic Surgical Backlogs Such as the One Following the COVID-19 Pandemic
Adám, H , Schuyver, Paul Van , Bingham, Joshua S. , Chhabra, Anikar , Adam, Henderson , Van Schuyver, Paul R , Economopoulos, Kostas J. , Bingham, Joshua S , Chhabra, Anikar

Mayo Clinic

JBJS Open Access | September 30, 2024 | Volume: 9 | Issue: 3 | Pages: No page available

10.2106/jbjs.oa.24.00100 | PMID 39301194 Get It

Abstract ➤ The COVID-19 pandemic created a persistent surgical backlog in elective orthopedic surgeries. ➤ Artificial intelligence (AI) uses computer algorithms to solve problems and has potential as a powerful tool in health care. ➤ AI can help improve current and future orthopedic backlogs through enhancing surgical schedules, optimizing preoperative planning, and predicting postsurgical outcomes. ➤ AI may help manage existing waitlists and increase efficiency in orthopedic workflows.
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
Seligson, Nathan D. , Chen, James L. , Goodrich, Austin C, Tine, Brian A. Van , Campbell, Jordan D., Richards, Allison L. , Milhem, Mohammed , Streicher, Howard , Tap, William D. , Van Tine, Brian A , D'Angelo, Sandra P , Milhem, Mohammed M , Antonescu, Cristina R. , Liebner, David A. , Schwartz, Gary K. , George, Suzanne

Mayo Clinic

Journal for ImmunoTherapy of Cancer | September 29, 2024 | Volume: 12 | Issue: 9 | Pages: e009472

10.1136/jitc-2024-009472 | PMID 39343511 Get It

Background In this open-label, randomized, non-comparative, multicenter phase II study (Alliance A091401) we report on three expansion cohorts treated with nivolumab (N) with and without ipilimumab (N+I) and provide a multi-omic correlative analysis of actionable biomarkers. Methods Patients were randomized (non-comparative) to receive either N or N+I. The primary endpoint was a 6-month confirmed response rate (CRR) defined by Response Evaluation Criteria in Solid Tumors version 1.1. Secondary endpoints included treatment-related adverse events (TRAEs), progression-free survival, and overall survival. Multi-omic correlative analyses were conducted using samples from both the primary and expansion cohorts. Results A total of 66 patients were evaluated for the primary endpoint with disease including gastrointestinal stromal tumor (GIST, n=18), undifferentiated pleomorphic sarcoma (UPS, n=24), and dedifferentiated liposarcoma (DDLPS, n=24). Neither N nor N+I achieved a complete or partial response in the GIST expansion cohort. In DDLPS and UPS, the primary response endpoint of CRR was met with N+I (both 16.6%, 2/12) but not with N alone (both 8.3%, 1/12). In the GIST cohort, TRAE was higher with N+I treatment, halting enrollment as required per protocol. In a correlative analysis of patients for the expansion cohort and the original cohort (n=86), traditional biomarkers of immunotherapy response were not correlated with response in any histological subtype. Markers of genomic instability including the presence of gene fusions and increased subclonal mutations correlated with improved clinical outcomes. Conclusions This expansion cohort reaffirms the outcomes of A091401. There remains a pressing need to determine the role of and predictive biomarkers for immunotherapy in sarcoma. Trial registration number NCT02500797.